Page last updated: 2024-12-08

2'-deoxy-3'-adenosine monophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2'-deoxy-3'-adenosine monophosphate: inhibitor of adenylate cyclase; see also record for 2',5' cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2'-deoxyadenosine 3'-monophosphate : A 2'-deoxyadenosine phosphate having a monophosphate group located at the 3'-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID167350
CHEMBL ID513308
CHEBI ID580387
SCHEMBL ID3502762
MeSH IDM0090985

Synonyms (25)

Synonym
2'-deoxy-adenosine 3'-monophosphate
1CS4
2'-deoxy-3'-amp
2'-deoxyadenosine 3'-monophosphate
CHEBI:580387 ,
2'-deoxy-3'-adenosine monophosphate
15731-72-3
2'-deoxy-3'-adenylic acid
CHEMBL513308
2'-deoxyadenosine 3'-phosphate
[(2r,3s,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate
3'-adenylic acid, 2'-deoxy-
2'-deoxyadenosine 3'-monophosphate sodium salt
SCHEMBL3502762
J-700036
2'-deoxyadenosine-3'-monophosphate, free acid (damp.h2)
2'-deoxyadenosine-3'-monophosphate
(2r,3s,5r)-5-(6-amino-9h-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl dihydrogen phosphate
desoxyadenosin-3'-monophosphat
9-(2-deoxy-3-o-phosphonopentofuranosyl)-9h-purin-6-amine
DTXSID10935657
Q27105175
2'-deoxy-d-adenosine 3'-monophosphate sodium salt
2/'-deoxyadenosine-3/'-monophosphate
A900763
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
2'-deoxyadenosine phosphate
purine 2'-deoxyribonucleoside 3'-monophosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYPE V ADENYLATE CYCLASECanis lupus familiaris (dog)IC50 (µMol)2.70002.70002.70002.7000AID977608
Chain B, TYPE II ADENYLATE CYCLASERattus norvegicus (Norway rat)IC50 (µMol)2.70002.70002.70002.7000AID977608
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID353131Inhibition of penicillin-resistant Streptococcus pneumoniae 159 recombinant MurM at 1 mM by liquid scintillation counting2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2000Biochemistry, Nov-28, Volume: 39, Issue:47
Molecular basis for P-site inhibition of adenylyl cyclase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's5 (55.56)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.67 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]